Market closedNon-fractional

Fortress Biotech/FBIO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Fortress Biotech

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Ticker

FBIO

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Bay Harbor Islands, United States

Employees

186

Fortress Biotech Metrics

BasicAdvanced
$39M
Market cap
-
P/E ratio
-$5.87
EPS
1.55
Beta
-
Dividend rate
$39M
1.55
1.329
1.071
-2,007.595
-2,251.994
-8.58%
-34.13%
-1,739.64%
0.221
1.51
9.8
-0.155
32.48%
-63.82%
24.35%
-11.40%

What the Analysts think about Fortress Biotech

Analyst Ratings

Majority rating from 4 analysts.
Buy

Fortress Biotech Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-118.46% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$13M
-34.67%
Net income
-$15M
67.39%
Profit margin
-118.46%
156.24%

Fortress Biotech Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 40.46%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$3.60
-$0.94
-$1.28
-$1.03
-
Expected
-$3.41
-$3.21
-$1.97
-$1.73
-$1.22
Surprise
5.49%
-70.68%
-34.92%
-40.46%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Fortress Biotech stock?

Fortress Biotech (FBIO) has a market cap of $39M as of July 06, 2024.

What is the P/E ratio for Fortress Biotech stock?

The price to earnings (P/E) ratio for Fortress Biotech (FBIO) stock is 0 as of July 06, 2024.

Does Fortress Biotech stock pay dividends?

No, Fortress Biotech (FBIO) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Fortress Biotech dividend payment date?

Fortress Biotech (FBIO) stock does not pay dividends to its shareholders.

What is the beta indicator for Fortress Biotech?

Fortress Biotech (FBIO) has a beta rating of 1.55. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Fortress Biotech stock

Buy or sell Fortress Biotech stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing